We compare region of interest (ROI) analytical approaches with statistical parametric mapping (SPM) of llC_ diprenorphine positron emission tomography findings in five patients with Huntington's disease (HD) and nine age-matched controls. The ROI were placed on caudate, putamen, and an occipital reference area. Ratios of striatal-occipital uptake from averaged static images centered at 60 minutes showed a mean 20% reduction in caudate (P = 0.034) and 15% reduction in putamen (P = 0.(95) receptor binding in the HD patients. Dynamic data from caudate and putamen ROI, together with a plasma tracer input function, were analyzed using spectral analysis to give l egional impulse response functions. Regional data at 60 minutes after impulse showed a mean 29% decrease in caudate (P = 0.006) and 23% decrease in putamen (P = 0.029) opioid binding in the HD cohort. Parametric images of tracer binding also were produced with spectral analysis on a voxel basis. The images of the unit impulse response function at 60 minutes showed a mean 31 % decrease in caudate (P = 0.005) and a 26% decrease in putamen binding (P = 0.011) in
Positron emission tomography (PET) studies of ligand binding in brain tissue can be analyzed in several ways. These range from relatively simple ratio techniques in volving comparisons of summated activity in tissue re gions of interest with that in a reference region, through to the analysis of dynamic data using more complex mathematical models. Whereas the latter approaches may give better and more physiologically relevant mea sures of receptor-ligand interactions, they involve more data processing and usually require invasive sampling of HD. The voxel-based parametric images were transformed into standard stereotactic space, and a between-group comparison (patient versus controls) was performed with SPM. This ap proach revealed symmetrical decreases in caudate (peak 40% decrease, z score = 4.38) and putamen opioid binding (peak 24% decrease, z score = 4.686) with additional nonhypoth esized changes in cingulate, prefrontal, and thalamic areas. The significance and precision of changes measured with spectral analysis applied to dynamic data sets were superior to ROI based ratio analysis on static images. The SPM replicated the striatal reductions in opioid binding in HD and detected addi tional nonpredicted changes. This study suggests that SPM is a valid alternative to conventional ROJ analytical approaches for determining binding changes with positron emission tomogra phy and may have advantages over region-based analyses in exploratory studies. Key Words: Huntington's disease Opioid receptors-PET -Spectral analysis-Tracer kinetics Statistical parametric mapping. arterial blood to generate an input function. Whether fit ted dynamic data is superior compared with simple ratio analysis in detecting pathologic change is uncertain. We therefore compare results from a region-based ratio analysis of static data with results obtained with spectral analysis of dynamic data from the same regions.
The manual definition of tissue regions and the sub sequent kinetic analysis of mean regional data require an a priori choice of the regions of interest (ROI). Whereas this approach has been successful in addressing several scientific issues, it is not without problems. Frequently, the size, shape, and number of regions chosen for analy sis and the number of planes of data on which they were placed has been subjective. Coregistered magnetic reso nance imaging and semiautomated routines can be used to help define region size, shape, and location and so eliminate the subjective component of region placement, but do not fully overcome the problems in identifying functionally distinct areas of cortex. In addition, the coregistration procedure transforms the PET data set and so introduces errors. These limitations of conventional ROI analysis have led us to assess the feasibility of using other techniques to analyze PET ligand scans.
Statistical parametric mapping (SPM) has been widely used to localize regions of activation in cerebral blood flow studies when tasks are performed by individuals and groups. Recently, it has been applied to the analysis of changes in radioligand binding (Richardson et aI., 1996; Koepp e t aI., 1996; Frey et aI., 1996) . We compare ROI analysis with SPM for ll C-dipren Ol phine PET in controls and patients with Huntington's disease (HD).
Huntington's disease is an autosomal dominant, neu rodegenerative condition that affects 1 in 20,000 of the population (Harper, 1992) . Postmortem studies in HD demonstrate reduced concentration of pallidal, striatal, and nigral enkephalin and dynorphin and also loss of basal ganglia opioid receptors (Seizinger et aI., 1986; Rostene et aI., 1988; Gulya, 1990) . These findings indi cate that the opioid system is extensively involved in the degenerative process of HD.
METHODS

Subjects
Five HD patients were recruited for the study (four men, one woman; mean age 46 years, range 31 to 68 years; mean disease duration 2.7 years). All patients had adult-onset chorea and mutation-confirmed Huntington's disease with a CAG tri nucleotide repeat length over 37 (Simpson and Harding, 1993) . The patients had never taken neuroleptic medication or medi cation known to interact with the opioid system. The results from the HD patients were compared with those of nine age matched healthy volunteers with normal neurologic status. None of the patients or healthy volunteers was in pain during the scan. The patients had only mild chorea and when resting supine did not exhibit axial or head movements. No data, there fore, had to be rejected from the study because of head move ment artifacts.
All subjects gave informed written consent. The studies were approved by the Hammersmith Hospital Medical Ethics Com mittee, and permission to administer radioactivity was obtained from the Administration of Radioactive Substances Advisory Committee of the Department of Health, UK.
Scanning procedure llC-diprenorphine was prepared as described previously (Luthra et aI., 1994) . The PET scans were performed on an ECAT 953B (Siemens/CPS, Knoxville, TN) brain tomograph in three-dimensional acquisition mode using a protocol based on a "tracer alone" study (Jones et aI., 1994) . Before admin istration of llC-diprenorphine, a lO-minute transmission scan was performed using rotating 6 8Ga/ 6 8Ge rod sources for sub sequent correction for attenuation of radiation in tissue. After the transmission scan, the interplane septa were removed for three-dimensional data acquisition (Spinks et aI., 1992) . The scatter component was estimated using a dual-energy window approach, and data were corrected for scatter by performing a weighted subtraction of low-energy events (200 to 380 ke V) J Cereb Blood Flow Metab. Vol. 17. No.9, 1997 from the high-energy window (380 to 850 keY) (Grootoonk et aI., 1992) .
An average of 9.8 mCi of l1C-diprenorphine in 5 mL of normal saline was injected as a bolus intravenous injection. Dynamic emission data were then collected over the following 90 minutes in 17 time frames and reconstructed into 31 con tiguous horizontal image planes. Data were reconstructed using a three-dimensional reconstruction algorithm (Townsend et aI., 1989) to obtain images with resolution of 6.0 x 6.0 x 5.0 mm (full-width half-maximum) at the center of the field of view.
Radioactivity in arterial blood was assayed continuously on line (Rani car et aI., 1991) , and intermittent blood samples were taken for calibration and for assay of radiolabeled metabolites in plasma. The derivation of a plasma input function from the data obtained from arterial blood has been described (Jones et aI., 1994) . The ratio of the concentration of total radioactivity in plasma to that in whole blood, as measured in the discrete blood samples, was fitted to a linear function of the time of sampling. The proportion of radioactivity in plasma recovered in the parent (non metabolized) fraction was fitted to a function describing an exponential approach to a constant fraction. These two fitted functions then were applied to the continuous on-line arterial data, which, after appropriate cross-calibration with the camera, gives a plasma parent input function for sub sequent kinetic analyses. It was assumed that only the parent tracer crosses the blood-brain barrier.
Analysis of images
Image analysis was performed using Analyze software (ver sion 6.1, Mayo Foundation, Rochester, MN, U.S.A.) (Robb, 1990) . Other software included PRO MATLAB (MathWorks, Natick, MA, U.S.A.) and routines developed in house.
The analysis of data was carried out in four ways. First, a ratio method was used comparing counts averaged over 30 to 90 minutes of scanning in predetermined ROl with those in an occipital reference region. Second, dynamic regional data ob tained with the same ROI template was fitted using spectral analysis to give 60-minute tis sue impulse response functions (IRF) reflecting regional vol ume of distribution of the tracer. Third, spectral analysis was performed on voxel-based dynamic data to produce images of the IRF to which ROI were then applied. Finally the voxel based parametric images were submitted to SPM. These meth ods are described in detail as follows.
Ratio method
Placement of ROI was determined by inspection of an image of summated tracer activity collected over the last 60 minutes of scanning, centered at the 60-minute time point. The ROI were placed on three areas: head of caudate, dorsal putamen, and an occipital reference area. The ROI for each of these structures were defined on the four adjacent horizontal planes, which showed maximal striatal activity. The striatal regions consisted of four circular ROI of 8.2-mm diameter, one placed over the head of caudate on each side and three placed contig uously over the putamen on each side. The occipital ROI com prised a circular region of 32.8-mm diameter placed over each hemisphere. Mean caudate-and putamen-occipital uptake ra tios for the normal and HD groups were calculated and com pared using the Student's t statistic.
Spectral analysis
Spectral analysis ) was applied to ROJ and also to voxel by voxel time-activity curves from the dynamic scan sequence. This technique fits each of the ob served tissue time-activity curves to a sum of basis functions spanning the expected tissue response. The basis functions were formed by convolving the measured plasma parent input function, Ca(t), with exponential terms of the form [exp(-b.t)] with a logarithmic range of 64 values of b. The data was fitted in nondecay-corrected form with values of b from 5.7 x 1O-4sec-1 (corresponding to the isotopic decay rate as the slow est expected component) to 1.0 sec-I. Estimates subsequently were corrected for decay of the isotope. This approach can be viewed as a smoothed deconvolution that allows the extraction of the unit IRF from the tissue data. The IRF is independent of the particular plasma input function in any one study and thus enables the suqsequent comparisons and combinations of data sets. The integral of the curve of best fit, extrapolated to time point infinity, provides the total volume of distribution of the ligand. Images of time points along the derived tissue response also can be generated. In practice, the volume of distribution images are noisy, and a 60-minute tissue impulse response image (IRF 6 0) was used for further analysis. This is discussed later.
First, time-activity curves for the caudate and putamen re gional data defined by the ROI template were fitted to create regional tissue response functions. Second, voxel-based time activity curves were submitted to spectral analysis, and the ROI template was applied to the voxel-generated IRF 6 0 parametric images. In effect, the two analytical techniques are similar, other than the fitting procedure and the region placement steps being reversed. However, the data from the region-based spec tral analysis allow for a more appropriate comparison with the region data obtained from the static ratio analysis. Comparisons of caudate and putamen activity in the patient and controls cohorts were made.
Statistical parametric mapping analysis
Voxel-based 1RF 6 o images from the patient and control co horts were compared using the technique of SPM (SPM-95, Well come Department of Cognitive Neurology, London, U.K.). To facilitate group analysis, the intercommissural (an terior commisure-posterior commissure) line was identified and the volume of each data set transformed into standard stereo tactic space (Friston et aI., 1991; Talairach and Tournoux, 1988) . These stereotactically normalized images contained 26 planes of 2 x 2 x 4 mm voxels corresponding to the horizontal sections in the Talairach atlas.
An analysis of covariance was applied to remove the effect of variance in global activity. Normalized mean activity and the associated variance of such values were determined for each voxel. Each image was smoothed with an isotropic Gaussian kernel of 10 mm. The resulting set of voxel values for the between-group contrasts constitute statistical parametric maps of the t statistic SPM {t}. The SPM {t} maps were transformed to the unit normal distribution (SPM{Z}) and thresholded at Z > 3.09 (equivalent to an uncorrected P < 0.001). The resulting foci then were characterized in terms of peak height estima tions. The significance of each region was estimated using distributional approximations from the theory of Gaussian Fields. This characterization is in terms of the probability that the peak height observed could have occurred by chance over the entire volume analyzed (i.e, corrected P value). Assessment of the peak height significance, therefore, included a correction for the number of independent voxels giving a final Z score for peak height significance of 4.35. The PET data set contained 36,417 voxels, 2 x 2 x 2 mm. After smoothing, there were 299 independent resolution elements of resolution 13.1, 14.4, and 10.4 mm (full-width half-maximum).
RESULTS
The results from the ROI analysis using the ratio method on static images centered at 60 minutes after injection and ROI-and voxel-based fits of the IRF60 are shown in Table 1 . All of these approaches show de creases in caudate and putamen opioid binding in RD. The results from the parametric data obtained by spectral analysis of the regional time-activity data demonstrate larger differences between patients and controls and greater statistical significance than the static ratio analy sis of the same regions. Spectral analysis, regardless of whether applied to ROI or voxel dynamic data sets, gave similar results. The coefficients of variability (standard deviation/means as a percentage [Woolson, 1987] ) are shown for the control group for each method and show The ratio analysis was performed on summed images centred on 60 minutes (i.e., 30 to 90 minutes after intravenous injection of tracer) as described in the Methods section. Parametric analyses were performed using spectral analysis and results are presented as the value of the unit impulse response function (sec -I) evaluated at 60 minutes. COY refers to coefficients of variability and are determined by the standard deviation/mean expressed as a percentage. The F values refer to a comparison of the COY between the fitted and the ratio data in which an F value of 3.44 was significant at a P level of 0.05. smaller variability with spectral analysis. The coeffi cients of variance from the ratio and fitted data were statistically compared using an F test. The results indi cate significantly larger variability for putamen measure ments in the ratio compared with the fitted data with nonsignificant differences for caudate values.
The results from the two between group SPM con trasts are given in Table 2 , and the SPM projections are illustrated in Figures 1 and 2 . Table 2 lists be led diprenorphine in vivo as a quantitative marker of cerebral opioid receptor sites have been carried out in rats and in humans using PET. The work in rats showed a close correlation between estimates of the regional con centrations of binding sites obtained from tracer studies in vivo with those obtained from studies in vitro on brain tissue homogenates (Cunningham et aI. , 199 1) . The analysis of the data in vivo was based on a compartmen tal model that subsequently was adapted for application to studies in humans using PET. Likewise, these studies The spatial coordinates correspond to the stereotactic conventions of the atlas of Talairach and Tournoux. The normalized voxel activities are relative to an arbitrary global mean voxel intensity of 50. The percentage change reflects the difference between the normalized voxel activity. The global activity was not significantly different between the two groups (two-tailed unpaired Student's t-test, P = 0.45). shown are significant at the uncorrected threshold Z > 2.56 equivalent to P < 0.005.
in humans established a close correlation between the regional bincfing potential of radio labeled diprenorphine, based on displacement and pre saturation studies, with its total volume of distribution as estimated from tracer alone studies (Jones et aI., 1994) .
Tracer alone studies do not allow robust estimates of individual rate constants or characterization of individual compartments, particularly at the voxel level. In the cur rent work, spectral analysis was chosen to generate IRF reflecting diprenorphine total volume of distribution, since it makes no assumptions regarding the number of physical compartments that are required to describe tracer kinetics. Early time points on the IRF are domi nated by the delivery of the tracer to brain and rCBF, whereas later images are increasingly dominated by binding and reflect the regional concentration of opioid receptor sites (Tadokoro et aI., 1993) . Whereas the inte gral of the IRF, extrapolated to time point infinity, equals the total volume of distribution of the tracer, this function tends to be noisy (Cunningham et aI. , 1993) . The 1RF6o parametric images were therefore chosen for the analyses carried out in the current work, since (unpublished) com puter simulations based on the rate constants in a study by Jones and others (1994) show that IRF60 parametric images correlate strongly with the regional total volumes of distribution, are relatively insensitive to regional dif ferences in flow and delivery of diprenorphine, and are well defined by the measured data.
We analyzed opioid receptor binding data from cau date and putamen using three techniques: (1) a ratio method of regional-reference activity in a static, aver aged scan centered at 60 minutes after injection; (2) spectral analysis of dynamic data on a voxel and on a regional basis generating IRF at 60 minutes; and (3) a group comparison of voxel-based parametric images us ing SPM.
Spectral analysis of ROI-generated dynamic data and ROI analysis of parametric data generated with spectral analysis both produced a pattern of results similar to the simple reference ratio method. However, the significance and magnitude of change in caudate and putamen bind ing were greater when dynamic time-activity curves were fitted using spectral analysis compared with the ratio analysis of averaged counts from a static image. In addition, the coefficients of variance from the ratio method were significantly larger than those with the fit ted data. This suggests that ROI analysis of parametric images is superior in terms of precision in normal sub jects and for distinguishing pathologic variation from normality compared with ROI analysis of static ratio images.
There are several reasons why the fitted data may be better than the ratio method. The ratio analysis includes data from an occipital reference region, which contains a low numbers of counts and is noisy. This adds variance to the ratio approach in comparison with spectral analy sis, which is based on striatal counts alone. The ratio method generally is used because of the lack of a mea surable input function, and thus it may seem obvious that the measurement of a physiologically meaningful input function would lead to improved results; however, this has to be balanced against the introduction of further measurements and their associated noise into the model. Spectral analysis, regardless of whether applied at a regional or voxel level, gave nearly identical results. As noted previously, the two procedures are similar in prin ciple, and so similar results would be expected. How ever, the analysis does confirm that spectral analysis per formed at a voxel level does not result in degradation of image quality or loss of statistical power.
It is difficult to directly compare the ROI analysis with SPM, since they analyze different aspects of receptor binding. The ROI techniques compare mean binding in predefined regions, whereas SPM measures peak differ ences on a voxel-by-voxel basis. It is, therefore, not sur prising that the peak percentage difference and statistical significance in the SPM analysis was greater than the differences found with ROl analysis. Given the differ ences of the two approaches, if mean binding estimate is desired such as putamen opioid receptor binding, an ROI-based techniques probably is most appropriate, whereas if an approach that objectively locates areas with maximal binding difference between two data sets is desired, SPM has advantages. The two techniques are not mutually exclusive, and, as in this study, a combina tion of approaches may be revealing.
The SPM technique can be used to directly compare quantitative PET data or can assess the relative regional distribution of a PET measured parameter after a nor malization procedure has removed the effect of global variance. In PET ligand studies, appropriate modeling of tracer behavior allows quantitative measurement. How ever, inaccuracies in scaling, input functions, and me tabolite corrections still can give rise to global variance, which can mask biological variation in regional uptake.
We therefore have included an analysis of covariance adjustment in this analysis and report the relative re gional distribution of binding changes. The use of analy sis of covariance and the sterotactic normalization also can be applied to data obtained with ROI, and so these techniques are not exclusive to SPM.
As an indirect validation of SPM, this approach more sensitively replicated the striatal opioid binding changes independently demonstrated with ROl analysis. The striatal changes detected with SPM were symmetrical, greater, and statistically more significant than those gen erated using ROI. Statistical parametric mapping also detected additional opioid binding changes in cortical areas that would have been difficult to predict a priori (cingulate, thalamus, and prefrontal). This method of analysis may be of considerable importance in future PET ligand work, since SPM is sensitive to change, avoids potential difficulties in region selection, and maximizes the ability to detect differences between data sets. The ROI analysis still has a major role in measuring ligand binding, but this study suggests that SPM is a viable alternative and has advantages, particularly in ex ploratory studies.
We now briefly discuss the biological significance of the regionally changed opioid receptor binding in the HD cohort.
Striatum
The earliest histochemical change in asymptomatic HD mutation carriers is reported to be loss of enkephalin binding in striatal projection neurons to the external glo bus pallidum (Albin et aI., 1992) . Postmortem studies in patients dying of HD have shown that the proenkephalin group of opioids is reduced in caudate, putamen, and internal and external pallidal tissue, whereas the pro dynorphin family is reduced in striatal, external pallidal, and nigral areas (Seizinger et aI., 1986 ). In the current study, the mean striatal opioid receptor binding of the HD patients was reduced by between 20% and 40%, depending on the analytical approach. We have previ ously demonstrated that both striatal dopamine D 1 and D2 receptor binding are reduced by an average of 60% in symptomatic cases of HD (Turjanski et aI., 1995) and that 50% of adult asymptomatic mutation carriers show a J Cereb Blood Flow Metab. Vol. 17. No.9. 1997 significant 20% to 30% loss (Weeks et aI., 1996) . Thus, it appears that opioid receptor sites are less vulnerable to the disease process than dopamine sites, possibly be cause of preservation of presynaptic opioid sites.
Thalamus
Statistical parametric mapping detected significantly increased thalamic opioid receptor binding in HD. The finding of increased thalamic availability for II C diprenorphine binding may reflect decreased occupancy by endogenous opioids, although up-regUlation of tha lamic receptors also is a possibility. Postmortem studies on patients with advanced disease have shown a 50% decrease in the small cell population of the ventrolateral group of the thalamus (Dom et aI., 1976) . It is conceiv able that with further disease progression and resulting thalamic degeneration, opioid receptor loss would fol low. In fact, we have subsequently scanned a patient with disease duration of 8 years who had significantly reduced individual thalamic-occipital ratios, adding weight to this hypothesis. Unfortunately, the patient was not able to tolerate arterial cannulation and so parametric images could not be generated.
Cortex
There has been debate over whether the cerebral cor tex is involved in the pathophysiologic mechanism of HD (Bruyn et aI., 1979; Cudkowicz and Kowall, 1990) .
We have demonstrated significant bilateral decreases in cortical opioid receptor binding in the anterior cingulate with increases in the prefrontal areas. However, the non specific nature of IIC-diprenorphine and the lack of knowledge of receptor SUbtype localization in cortical areas makes further interpretation of the cortical changes in this study difficult.
CONCLUSION
We have compared different ROI-based analytical ap proaches and SPM of IIC-diprenorphine PET scans in five patients with early HD and nine age-matched healthy volunteers. Our findings suggest that the differ ent ROJ approaches and SPM lead to similar findings for striatal opioid binding, although the significance and pre cision of ROJ analysis when coupled with spectral analy sis of dynamic data sets is superior to ratio analysis of static images. Statistical parametric mapping also dem onstrated additional unpredicted changes in opioid bind ing in cingulate and prefrontal cortex. This study sug gests that SPM analysis of PET ligand studies is a viable alternative to conventional ROI analysis and may in ex ploratory studies reveal unexpected regional binding changes.
